Bicalutamide Key patent SPC and data exclusivity expiry 7 country coverage

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

B.M.P. Pharma Trading AG (Symbol:BMP) SWOT Analysis, Strategy, Revenues and Profits

B.M.P. Pharma Trading AG (Symbol:BMP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. B.M.P. Pharma Trading AG SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Australia

BDH Industries Ltd. (Symbol:524828) SWOT Analysis, Strategy, Revenues and Profits

BDH Industries Ltd. (Symbol:524828) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BDH Industries Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Philippines, India, Australia, Switzerland, Sri Lanka, Singapore

Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Pharmanet Group Ltd SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Australia

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary IPCA Laboratories Limited (IPCA) is a generic pharmaceutical company. It undertakes the manufacturing and distribution of active pharmaceutical ingredients and formulations. The company's APIs products include Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol ...

Industries: Drug and Medication | Countries: Canada, India, Australia

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: India, United States, World, Australia, South Africa, China

Australia Pharmaceuticals and Healthcare Report Q1 2015

Australia Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 142 pages

Includes 3 FREE quarterly updates BMI View: The Australian government will continue to use drug price controls as a means to reduce healthcare expenditure. Our view is based on the government's runaway budget deficit and the inevitable increased demand for medicines as the population ages and incidence ...

Industries: Drug and Medication | Countries: Australia

Cancer Drug News 20 OCTOBER 2014

Cancer Drug News 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • October 2014
  • 16 pages

Industry Trend Analysis - Fully Personalised Cancer Vaccines On The Rise Industry Trend Analysis - Pfizer's Palbociclib On Route For 2015 Launch Industry Brief - Galena Receives Japanese Patent Allowance Covering NeuVax Industry Brief - Pharmacyclics/Roche Enter Deal To Evaluate Imbruvica/Gazyva In Lymphoma ...

Industries: Drug and Medication | Countries: Australia, Canada, Japan

Australia Hyperbaric Oxygen Chambers Market Outlook to 2020

Australia Hyperbaric Oxygen Chambers Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 26 pages

Australia Hyperbaric Oxygen Chambers Market Outlook to 2020 Summary GlobalData's new report, "Australia Hyperbaric Oxygen Chambers Market Outlook to 2020", provides key market data on the Australia Hyperbaric Oxygen Chambers market. The report provides value, in millions of US dollars, volume (in units) ...

Industries: Drug and Medication | Countries: Australia

Synthon BV SWOT Analysis, Strategy, Revenues and Profits

Synthon BV SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • October 2014
  • 26 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: Australia, Netherlands, United States

Abacavir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Drug and Medication | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.